Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells

Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651015/?tool=EBI

Similar Items

Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
by: PLOS ONE Editors
Published: (2023-01-01)

Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
by: Yong-Chao Ma, et al.
Published: (2016-01-01)

Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
by: Jayanthan Aarthi, et al.
Published: (2011-12-01)

Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ
by: Cole A. Fief, et al.
Published: (2019-02-01)

Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis
by: Mohamed A. Elanany, et al.
Published: (2023-03-01)

Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.
by: Myriam V Valenzuela, et al.
Published: (2020-01-01)

Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors
by: Kanyani Sangpheak, et al.
Published: (2019-03-01)

Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines
by: Kanyani Sangpheak, et al.
Published: (2019-01-01)

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
by: Hamada H. H. Mohammed, et al.
Published: (2022-12-01)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
by: Sachin Gupta, et al.
Published: (2008-10-01)

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
by: Mattias F. Lindberg, et al.
Published: (2021-06-01)

Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors
by: Wei Zhou, et al.
Published: (2020-07-01)

To Investigate the Electrochemical Behaviors of Bis-Chalcone Derivatives
by: Neslihan NOHUT MAŞLAKCI, et al.
Published: (2020-06-01)

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.
by: Besma Aouar, et al.
Published: (2016-01-01)

Chalcones as Potential Inhibitors of Pancreatic Lipase
by: Sílvia Rocha, et al.
Published: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
by: Mark C Weir, et al.
Published: (2017-01-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
by: Ronnakorn Leechaisit, et al.
Published: (2023-08-01)

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
by: Miriam Sartages, et al.
Published: (2020-12-01)

Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in <i>Mycoplasma hominis</i> Topoisomerases
by: Martin Sharratt, et al.
Published: (2021-11-01)

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
by: Miguel Piris-Villaespesa, et al.
Published: (2020-04-01)

Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
by: Wen-Bin Ou, et al.
Published: (2011-01-01)

Identification of annotation artifacts concerning the chalcone synthase (CHS)
by: Martin Bartas, et al.
Published: (2023-06-01)

The Synthesis and Spectral Properties of Benzofuran Derivative bis-Chalcone
by: Neslihan Beyazit
Published: (2018-03-01)

Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes
by: Xiaohua Jiang, et al.
Published: (2023-07-01)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
by: Jau-Lang Hwang, et al.
Published: (2009-03-01)

Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains
by: Jose Manuel Tirado-Vélez, et al.
Published: (2021-05-01)

Exploring the active site of the Streptococcus pneumoniae topoisomerase IV–DNA cleavage complex with novel 7,8-bridged fluoroquinolones
by: Ivan Laponogov, et al.
Published: (2016-01-01)

Eugenol derivatives containing 1,2,3-triazole-chalcone hybrids for shikimate kinase inhibition
by: Bayu Ardiansah, et al.
Published: (2024-03-01)

Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
by: Inken Flörkemeier, et al.
Published: (2022-09-01)

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
by: Tähtinen Siri, et al.
Published: (2010-01-01)

A phase II study of Bruton’s tyrosine kinase inhibition for the prevention of anaphylaxis
by: Ragha V. Suresh, et al.
Published: (2023-08-01)

Dual role of topoisomerase II in centromere resolution and aurora B activity.
by: Paula A Coelho, et al.
Published: (2008-08-01)

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
by: Ranjithkumar Rajendran, et al.
Published: (2021-05-01)

Tyrosine kinase inhibition: the new front in HIV cure efforts
by: V. Planelles, et al.
Published: (2019-12-01)

Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Enterococcus faecalis Isolated from Urinary Tract Infections
by: Esfahani S, et al.
Published: (2020-02-01)

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition
by: Dionysis Nikolopoulos, et al.
Published: (2023-06-01)

FIKK Kinase, a Ser/Thr Kinase Important to Malaria Parasites, Is Inhibited by Tyrosine Kinase Inhibitors
by: Benjamin C. Lin, et al.
Published: (2017-10-01)

Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
by: Sathya Selvarajan, et al.
Published: (2019-10-01)

A Src-like inactive conformation in the abl tyrosine kinase domain.
by: Nicholas M Levinson, et al.
Published: (2006-05-01)

A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma
by: Esteban J. Rozen, et al.
Published: (2024-01-01)